Ipca Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for IPCA LABS, and what generic and branded alternatives to IPCA LABS drugs are available?
IPCA LABS has thirty approved drugs.
Summary for Ipca Labs
| US Patents: | 0 |
| Tradenames: | 27 |
| Ingredients: | 26 |
| NDAs: | 30 |
Drugs and US Patents for Ipca Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ipca Labs Ltd | HYDROCHLOROTHIAZIDE | hydrochlorothiazide | CAPSULE;ORAL | 079237-001 | Apr 2, 2009 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ipca Labs Ltd | RISPERIDONE | risperidone | TABLET;ORAL | 205104-004 | Jun 26, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ipca Labs Ltd | IRBESARTAN | irbesartan | TABLET;ORAL | 211056-002 | May 22, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ipca Labs Ltd | IRBESARTAN | irbesartan | TABLET;ORAL | 211056-001 | May 22, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ipca Labs Ltd | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET;ORAL | 078422-002 | Aug 6, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Ipca Labs Ltd | GABAPENTIN | gabapentin | CAPSULE;ORAL | 208928-003 | Nov 20, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ipca Labs Ltd | LOSARTAN POTASSIUM | losartan potassium | TABLET;ORAL | 200290-003 | Aug 30, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
